Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

PURPOSE: On the basis of the ACCORD trial, FOLFIRINOX is effective in metastatic pancreatic adenocarcinoma (PDAC), making it a rational choice for locally advanced PDAC (LA). Aims of this study are to evaluate the accuracy of imaging in determining the resectability of PDAC and to determine the surg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg
Main Authors: Ferrone, Cristina R., Marchegiani, Giovanni, Hong, Theodore S., Ryan, David P., Deshpande, Vikram, McDonnell, Erin I., Sabbatino, Francesco, Santos, Daniela Dias, Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Faris, Jason E., Goyal, Lipika, Kwak, Eunice L., Murphy, Janet E., Ting, David T., Wo, Jennifer Y., Zhu, Andrew X., Warshaw, Andrew L., Lillemoe, Keith D., Castillo, Carlos Fernández-del
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349683/
https://ncbi.nlm.nih.gov/pubmed/25599322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000000867
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados